Logo image of PRFX

PAINREFORM LTD (PRFX) Stock Overview

NASDAQ:PRFX - IL0011651580 - Common Stock

1.38 USD
-0.07 (-4.83%)
Last: 9/2/2025, 8:27:00 PM
1.38 USD
0 (0%)
After Hours: 9/2/2025, 8:27:00 PM

PRFX Key Statistics, Chart & Performance

Key Statistics
52 Week High16.63
52 Week Low1.25
Market Cap2.77M
Shares2.01M
Float1.81M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-32.16
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO09-01 2020-09-01
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals


PRFX short term performance overview.The bars show the price performance of PRFX in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -10 -20 -30 -40 -50

PRFX long term performance overview.The bars show the price performance of PRFX in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of PRFX is 1.38 USD. In the past month the price increased by 2.31%. In the past year, price decreased by -77.65%.

PAINREFORM LTD / PRFX Daily stock chart

PRFX Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 45.52 695.83B
JNJ JOHNSON & JOHNSON 17.81 428.83B
NVO NOVO-NORDISK A/S-SPONS ADR 14.38 250.52B
AZN ASTRAZENECA PLC-SPONS ADR 18.06 248.63B
NVS NOVARTIS AG-SPONSORED ADR 14.31 245.16B
MRK MERCK & CO. INC. 11.1 213.51B
PFE PFIZER INC 7.37 142.03B
SNY SANOFI-ADR 11.14 120.92B
BMY BRISTOL-MYERS SQUIBB CO 7.04 96.50B
GSK GSK PLC-SPON ADR 8.6 78.49B
ZTS ZOETIS INC 24.58 67.75B
TAK TAKEDA PHARMACEUTIC-SP ADR 52.28 47.88B

About PRFX

Company Profile

PRFX logo image PainReform Ltd. is a pharmaceutical company, which focuses on reformulation of established therapeutics. The Company’s main activity is to develop reformulation of established pain therapeutics. PainReform Ltd provides technology, which is dedicated to prolong and enhance efficacy, minimize adverse effects and increase patients convenience as well as faster return of motor function.

Company Info

PAINREFORM LTD

65 Yigal Alon St.

TEL AVIV-YAFO 6745442 IL

CEO: Ilan Hadar

Employees: 4

PRFX Company Website

PRFX Investor Relations

Phone: 97237177051

PAINREFORM LTD / PRFX FAQ

What is the stock price of PAINREFORM LTD today?

The current stock price of PRFX is 1.38 USD. The price decreased by -4.83% in the last trading session.


What is the ticker symbol for PAINREFORM LTD stock?

The exchange symbol of PAINREFORM LTD is PRFX and it is listed on the Nasdaq exchange.


On which exchange is PRFX stock listed?

PRFX stock is listed on the Nasdaq exchange.


What is PAINREFORM LTD worth?

PAINREFORM LTD (PRFX) has a market capitalization of 2.77M USD. This makes PRFX a Nano Cap stock.


How many employees does PAINREFORM LTD have?

PAINREFORM LTD (PRFX) currently has 4 employees.


What are the support and resistance levels for PAINREFORM LTD (PRFX) stock?

PAINREFORM LTD (PRFX) has a support level at 1.32 and a resistance level at 1.89. Check the full technical report for a detailed analysis of PRFX support and resistance levels.


Should I buy PAINREFORM LTD (PRFX) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does PAINREFORM LTD (PRFX) stock pay dividends?

PRFX does not pay a dividend.


What is the Price/Earnings (PE) ratio of PAINREFORM LTD (PRFX)?

PAINREFORM LTD (PRFX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-32.16).


What is the Short Interest ratio of PAINREFORM LTD (PRFX) stock?

The outstanding short interest for PAINREFORM LTD (PRFX) is 6.18% of its float. Check the ownership tab for more information on the PRFX short interest.


PRFX Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to PRFX. When comparing the yearly performance of all stocks, PRFX is a bad performer in the overall market: 97.8% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

PRFX Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to PRFX. PRFX scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

PRFX Financial Highlights

Over the last trailing twelve months PRFX reported a non-GAAP Earnings per Share(EPS) of -32.16. The EPS increased by 81.23% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -322.39%
ROE -799.78%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%53.95%
Sales Q2Q%N/A
EPS 1Y (TTM)81.23%
Revenue 1Y (TTM)N/A

PRFX Forecast & Estimates


Analysts
Analysts43.33
Price TargetN/A
EPS Next Y38.91%
Revenue Next YearN/A

PRFX Ownership

Ownership
Inst Owners0.72%
Ins OwnersN/A
Short Float %6.18%
Short Ratio0.03